Patent ID: 11951172
Assignee: CRESCENDO BIOLOGICS LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 12:
13. The method according to claim 12, wherein said cancer is selected from bone cancer, pancreatic cancer, skin cancer, cancer of the head or neck, cutaneous or intraocular malignant melanoma, uterine cancer, ovarian cancer, rectal cancer, cancer of the anal region, stomach cancer, testicular cancer, breast cancer, brain cancer, carcinoma of the fallopian tubes, carcinoma of the endometrium, carcinoma of the cervix, carcinoma of the vagina, carcinoma of the vulva, cancer of the esophagus, cancer of the small intestine, cancer of the endocrine system, including cancer of the thyroid gland, cancer of the parathyroid gland or cancer of the adrenal gland, kidney cancer, including renal cancer, sarcoma of soft tissue, cancer of the urethra, cancer of the bladder, urothelial carcinoma, lung cancer, including non-small cell lung cancer, thymoma, a leukemia, prostate cancer, mesothelioma, adrenocortical carcinoma, a lymphoma, including Hodgkin's disease or non-Hodgkin's lymphoma, or a multiple myeloma.